Chemical Peel Consent Form Template: What to Include

Not medical or legal advice. What follows describes the usual structure and content of chemical peel consent forms. It recommends no peel agent, strength or technique, creates no clinical standard, and is not a statement of any state's law. Every consent form needs your medical director's approval before patients see it, and healthcare counsel familiar with your state's consent, scope and records rules should review it.

Peels are often the first clinical service a med spa adds and the last one anyone thinks to re-examine. The menu grows from one gentle exfoliating peel to a range of products, a series package, a "peel plus" upgrade, perhaps a stronger option performed by a nurse or physician on certain days. The consent form, meanwhile, is frequently a single page written for the first peel the practice ever offered. When a patient later develops a patch of dark pigment or a slow-healing area on the cheek, that page is the first thing anyone reads, and it is often the page that lets the practice down.

This guide works through the questions a practice owner, treating practitioner or medical director should be able to answer about peel consent: how the form relates to the consent conversation, who should hold that conversation, what elements the form needs, how depth changes it, whether a free template is usable, and how the signed form is stored and refreshed across a series. It deliberately gives no acid strengths, pH values, application counts, contact times or recovery periods. Those numbers belong in a protocol your medical director signs, matched to the products you actually stock.

Is a Chemical Peel Consent Form the Same as Informed Consent?

No. Informed consent is the process: a qualified practitioner explains the peel, the reasonable alternatives and the risks, answers the patient's questions and confirms that the patient wants to proceed. The signed form is the record that the process happened, and a defensible chart needs both.

Peels make this distinction easy to lose, because many practices treat them as a retail-adjacent service. A patient books a "glow peel" online, arrives, signs a tablet at reception and is in the chair within minutes. Nothing in that sequence is necessarily wrong, but if the only evidence of consent is the tablet signature, the practice has proved very little. A board investigator or a claimant's lawyer will ask a narrower set of questions. Who explained this particular peel? Was the patient told that their skin type carried a higher pigment risk? Did anyone ask about the retinoid cream they had been using? Did they know the skin might peel visibly in front of colleagues? The form can answer some of those questions only if it was written to.

What the discussion adds that paper cannot

A printed form speaks to every patient in the same words. The discussion is where those words are applied to the person in the chair. A patient with a history of cold sores, a patient who tans every summer, a patient preparing for a wedding, a patient with deeply pigmented skin and a patient who has used prescription acne medication all need a slightly different conversation about the same peel. The practitioner should be able to say, and preferably to record, which of those factors came up.

A brief practitioner note written at the visit closes that gap. It need not be long: who held the discussion, that questions were answered, which individual risk factors were discussed, and any change of plan that resulted. Paired with a well-drafted form, that note is far stronger evidence than either one alone.

What the signature actually establishes

A signed peel consent establishes, at most, that this patient, on this date, before this peel, saw this wording and agreed. It is undermined by anything that breaks one of those links: a form without a date, a superficial-peel form used for a stronger peel, a form signed after the solution was applied, or a template so generic it does not mention the peel at all. The value of the form lies in how closely it matches what happened, not in how many paragraphs it contains.

Who Can Perform a Chemical Peel, and Who Should Obtain Consent?

Who may perform which depth of peel varies by state and by licence, and the answer for an esthetician, a registered nurse and a physician can differ sharply even within one state. Check your state's rules in our med spa regulations by state directory and our esthetician scope of practice by state guide before you assign a peel to anyone.

The consent conversation belongs with someone who can answer the patient's clinical questions about the specific peel being offered. Where a superficial peel is lawfully performed by a licensed esthetician without medical involvement, that will often be the esthetician who performs it. Where a peel is treated as a medical procedure in your state, the conversation should be held by a clinician acting within their own scope, and the examination that precedes a delegated treatment is a separate requirement covered in our good-faith exam guide. In neither case should consent be handed to a receptionist, a sales coordinator or anyone who could not explain what a listed risk means.

Whatever the arrangement, the form should be honest about it. If one person discussed the peel and another applied it, give each a line with a printed name and credential. A form that suggests the person who applied the peel also assessed the patient, when the chart shows otherwise, invites exactly the scrutiny the practice wants to avoid.

What Must a Chemical Peel Consent Form Include?

A chemical peel consent form must name the peel and its depth category, describe expected peeling and downtime in general terms, set out alternatives and common effects, and name each material risk individually. Screening questions the practitioner reviews, photography consent, the patient's sun-protection and aftercare commitments, warning signs, and dated patient and practitioner signatures complete the form.

Compare your existing form against this list. Each element is explained in the sections that follow.

1. Peel type and depth category — the agent or product used, and whether the peel is intended as superficial, medium or deep, in general terms.
2. Expected peeling and downtime — what the skin is likely to do afterwards and that recovery varies, without fixed timetables.
3. Alternatives — other treatments, a gentler or stronger peel, and no treatment.
4. Common effects — the expected, usually temporary reactions, kept separate from the risks.
5. Risks to disclose — prolonged redness; hyperpigmentation or hypopigmentation, especially in darker skin types; scarring; infection; reactivation of cold sores (herpes simplex); and irritant or allergic reaction.
6. Screening questions — isotretinoin, retinoid use, active infection, keloids or poor healing, recent sun exposure and pregnancy, which the patient completes and the practitioner checks.
7. Photography consent — clinical photographs for the chart, with any marketing use authorized separately.
8. Sun-protection and aftercare commitments — what the patient agrees to do after the peel, with detail on a separate handout.
9. Warning signs — the symptoms that mean the patient should contact the practice, and how to reach someone.
10. Signatures and date — the patient's statement, signature and date; the practitioner's printed name, credential and signature; the form version.

Peel type and depth category

Begin by stating what is being applied. "Chemical peel" on its own describes nothing a reviewer can test. Name the agent or the product, and state the depth category the peel is intended to reach. In general terms, a superficial peel is designed to act on the outer layer of the skin, a medium peel is designed to reach into the upper dermis, and a deep peel is designed to reach further into the dermis. Those three labels are the vocabulary your state's rules, your protocol and your form should all share, so that when someone compares the three documents they describe the same treatment.

If your practice offers several peels, either use a separate form for each depth category or leave a clearly marked field for the specific peel used at the visit, completed before treatment. The worst arrangement is a form that lists every peel on the menu with no indication which one the patient received; it tells a reviewer that the practice did not think consent had to be specific.

Whether the form itself prints the strength of the solution is a choice for your medical director. Some practices name the product and refer to the treatment record for its formulation; others print the formulation on the form. If yours does print it, take it from your approved peel formulary and update the form every time the formulary changes. Do not copy a strength from a template or a supplier's brochure.

Expected peeling and downtime, in general terms

Patients choose peels around their diaries, so the downtime section is read closely and remembered. Describe it honestly but without a stopwatch: that the skin may feel tight and look red after treatment, that visible flaking or sheeting may follow and is more likely after stronger peels, that some superficial peels produce little visible peeling at all, and that the length and intensity of recovery increase with depth and vary between people. Add that the visible absence of peeling does not mean the peel did not work, which heads off a common complaint.

Keep specific recovery periods off the consent form. A number printed on a signed document becomes a promise, and recovery from the same peel differs between patients. If your medical director wants patients to have an approximate window, it belongs on the aftercare handout for that depth, where our aftercare guidance places it, and where it can be revised alongside the protocol.

Alternatives the patient could choose instead

Informed consent requires that the patient understood they had other options. For a peel these typically include a milder or stronger peel, a series of lighter peels instead of a single stronger one, topical skincare, other resurfacing treatments such as laser or microneedling, and no treatment at all. The form need not rank the alternatives or argue against them. It should record that they were raised, and it should state that results vary, that more than one session may be suggested, and that the practice does not guarantee a particular cosmetic outcome.

Common effects the patient should expect

Set out what ordinary recovery looks like in a separate list from the risks, so that a patient does not phone in alarm about something normal and so that a genuine complication is not dismissed as normal. Typical entries include stinging or warmth during application, redness, tightness, dryness, flaking or peeling, temporary sensitivity to skincare products, and a temporary change in skin tone while the outer layer renews. Note that these generally settle as the skin recovers and that stronger peels produce more of them.

Risks the form must name

Every risk on this list deserves its own line, in plain words, with a short explanation of what it would mean for the patient. These are the disclosures a dispute turns on.

• Prolonged redness. Redness that lasts well beyond the expected recovery period can occur, particularly with stronger peels or in sensitive skin. It can be distressing and may need follow-up.
• Hyperpigmentation or hypopigmentation. Treated skin can darken as it heals, and it can lose pigment. The form should state plainly that the risk of pigment change is higher in darker skin types and after recent sun exposure, that darkening can be slow to fade, and that loss of pigment may be permanent.
• Scarring. Scarring is uncommon but can be permanent. It is more likely if the skin becomes infected, if peeling skin is picked, after deeper peels, and in people who form raised or keloid scars.
• Infection. A peel weakens the skin's barrier while it recovers. Bacterial or fungal infection can follow, and needs prompt assessment.
• Herpes simplex reactivation. Patients with a history of cold sores may have an outbreak triggered by a facial peel, and an outbreak on freshly peeled skin can spread and scar. Ask about previous cold sores on the form, and make sure the chart shows the practitioner talked it through.
• Allergic or irritant reaction. The peel solution, the preparation products and the post-peel products can each cause irritation, rash or an allergic reaction. Severe allergic reactions are rare but are a medical emergency.

Your medical director may add others depending on your agents, depths and patients: for instance, burns or blistering from a peel that penetrates further than intended, demarcation lines where treated skin meets untreated skin, acne flares, or an uneven or disappointing result. Our laser and chemical peel complications guide covers how each of these is recognized, managed and documented, so the consent form does not need to explain management.

Avoid comforting adjectives. "Rare," "minimal" and "very safe" each imply a frequency your practice is unlikely to be able to support, and they read badly when the risk has just materialized. State that the risk exists, that it can happen even when the peel is correctly performed, and that some outcomes may be lasting.

Screening questions for the practitioner to review

The form, or the intake document it refers to, should put a short set of screening questions to the patient and give the practitioner space to record that the answers were reviewed before the peel. These are questions to inform a clinical judgement, not rules printed for the patient. What a given answer leads to, whether going ahead, adjusting the plan, waiting or declining, is the practitioner's call within the protocol your medical director has signed, and the form should make that clear to the patient. Typical questions include:

• Have you ever been prescribed isotretinoin for acne, and when was your most recent dose?
• Do you currently use a retinoid or other prescription or exfoliating skincare product, and when did you last apply it?
• Do you have a cold sore, rash, open wound or any other active skin infection in or near the area to be treated?
• Have you ever formed keloids or raised scars, or do you heal slowly or poorly after cuts or procedures?
• Have you had significant sun exposure, a sunburn, a tan or used self-tanner or a tanning bed recently?
• Is there any chance you are pregnant, are you planning a pregnancy, or are you breastfeeding?
• Have you ever had cold sores on your face?
• Do you have any allergies, including to skincare ingredients, aspirin or other medicines?

Your medical director may add questions about recent waxing, laser or other procedures in the area, medicines that increase sensitivity to light, or conditions that affect healing. Have the patient sign and date their answers, and have the practitioner initial that they were reviewed. If an answer changed the plan, the treatment note should say how.

Resist the temptation to print clinical instructions next to the questions, such as how long to stop a retinoid before treatment or how long after isotretinoin a peel may be considered. Those intervals are protocol decisions, they differ between agents and depths, and a printed rule on a patient form can contradict the protocol your medical director actually approved. The question goes on the form; the rule stays in the protocol. Keeping the health history behind those questions up to date is the subject of our intake form template guide.

Photography consent

Photographs before and after a peel are the clearest record of what the skin looked like, and after a pigment complication they are often the most important document in the chart. Standardize lighting, position and distance so that comparisons are meaningful, and include consent to clinical photography on the peel form. Consent to use those photographs in advertising, on social media or on the website is a separate decision. It needs its own written authorization that the patient can revoke, kept apart from the treatment consent, so that permission to photograph for the chart is never taken as permission to publish. Our before-and-after photo rules guide deals with the marketing side.

Sun-protection and aftercare commitments

Peel outcomes depend heavily on what the patient does afterwards, and for pigment in particular the patient's own behavior is a large part of the result. The consent form is the right place to record that the patient understood this and agreed to the core commitments: protecting the treated skin from the sun as instructed, not picking, pulling or scrubbing peeling skin, avoiding the products the practitioner has asked them to pause, and following the written aftercare they were given. A line for the patient to initial against these commitments is common and useful.

The detailed instructions themselves belong on a separate handout for the depth of peel performed, approved by your medical director and revised with the protocol. Why one sheet for every depth is a mistake, and what a peel handout needs instead, is explained in our aftercare instructions template guide. The consent should state that the handout was given and gone through with the patient, and the chart should record which version.

Warning signs and how to get help

Warning signs are part of the risk disclosure and so belong on the consent form as well as the handout. Tell the patient to contact the practice if redness, pain or swelling gets worse instead of better, if blisters form, if areas become raw, weep or crust beyond what was described, if they see pus, spreading crusts or a cold sore, if they develop a fever, if the skin darkens or lightens in patches, or if a rash or hives appear. Swelling of the face, lips or throat, or difficulty breathing, should be treated as an emergency. Give a number that is answered out of hours, or state what the patient should do when the practice is closed. A warning list with no reachable contact is only half a disclosure.

Signatures, date and practitioner identity

Close the form with a short, first-person attestation: that the patient has read it, was invited to raise questions and received answers, gave accurate health information and agrees to the named peel. The patient signs and dates it before any product touches the skin. Beneath that, the practitioner who explained the peel adds a printed name, licence type and signature. If the assessment and the application were done by different people, each appears on the form. Print the form's version number in the footer. Whether a witness signature is needed is a question for counsel; where one is used, the witness must actually have been present.

Asking the patient to initial each named risk is a common addition. It does not replace the conversation, but it leaves little room for a later claim that one specific risk was never shown to them.

Do Deeper Peels Need a Different Consent Form?

Yes, in substance if not always on separate paper. The consent should reflect the risks of the depth actually performed and the scope of the practitioner performing it, so a form written for a superficial peel cannot carry a medium or deep peel. Deep peels in particular are generally physician territory, and their consent should be built with that physician.

As depth increases, almost every section of the form changes. The expected course is more visible and longer. Pigment change, scarring and infection become more prominent and some risks that are marginal for a light peel become central. Screening becomes more searching, and the alternatives discussion widens to include other resurfacing options. Our skin and laser compliance guide explains why medium and deep peels are treated as medical procedures in most states and describes deep peels as effectively surgical work that belongs with a physician personally; a consent form for that work should come from the physician's own practice documentation rather than from a med spa's general peel template.

The practical safeguards are straightforward. Keep a separate form, or a clearly separate section with its own signature, for each depth category your practice performs. Make the depth on the form match the depth in the treatment note. And never let a stronger peel be performed under a form drafted for a lighter one because the stronger option was agreed in the chair; stop, complete the correct form, and have the right practitioner hold the discussion.

Is There a Free Chemical Peel Consent Form PDF?

There are plenty of free chemical peel consent forms online, but treat any of them as a starting point only. Before any patient sees it, the form has to fit the peel agents on your shelf and the scope rules of your state, be redrafted in your own language, and carry your medical director's approval.

Free templates go wrong in familiar ways. Many were written around one supplier's product and name it throughout. Many print a strength, an application count or a recovery period that will not match your formulary. Some cover every depth in one paragraph, so the light-peel patient is told about risks they will not face and the stronger-peel patient is not told enough. Some were drafted in a state where the peel is performed under a supervision arrangement you do not use. Some include fixed pre-treatment instructions, such as when to stop a retinoid, that nobody in your practice has approved. And many say almost nothing about darker skin types, which is where peel complaints concentrate.

Used carefully, a free template is still useful as a checklist. Compare it against the elements on this page, remove anything that does not reflect your practice, add the disclosures your agents and depths require, and log who approved it and from which date it applies. Then have healthcare counsel review it.

How Should Darker Skin Types Be Addressed on the Form?

Directly. The form should state that the risk of pigment change after a peel is higher in darker skin types and after recent sun exposure, and the chart should show that the practitioner raised it with the patients it most affects. A vague reference to "temporary discoloration" is not an adequate disclosure for those patients.

Two practical points follow. First, record the patient's skin type assessment in the chart before the peel; our complications guide treats that assessment as a documentation cornerstone for any acid-based treatment, and a consent form that discusses pigment risk reads far better beside a recorded assessment. Second, if your protocol uses a patch test or a cautious first session for some patients, mention on the form that the practitioner may recommend one, without promising that it removes the risk. Patients who understood in advance why their treatment plan was more conservative are less likely to feel they were treated differently without reason.

How Should You Document and Store Chemical Peel Consent?

A signed peel consent carries weight only alongside the rest of the chart. Filed with a treatment note that names the same peel, a skin-type assessment, reviewed screening answers and baseline photographs, it tells a coherent story. On its own it tells very little.

Linking the consent to the treatment record

Each peel visit should leave behind the signed consent, or a pointer to the one currently in force; the screening answers and the practitioner's review; the skin-type assessment; the examination or order where the peel is a delegated medical procedure; the agent and its formulation, how it was applied and how it was neutralized or removed where relevant, as your protocol requires; the areas treated; any preparation or post-peel products used; baseline photographs; and confirmation that the aftercare handout was given. The depth category on the consent should match the treatment note. Where the two differ, the chart needs a note explaining why and showing the patient agreed before the peel went ahead. Recording product lot details supports traceability if a supply problem is later identified.

How long to keep signed peel consent forms

The signed consent is part of the medical record, so it is retained for as long as the chart is retained. That period comes from state law and related obligations, and records of minors are often treated differently; peels have no special retention clock of their own. To work out the period that applies to you, use our medical records retention guide.

Keep every superseded version of the template as well as the signed copies. When a former patient raises a complaint, the question is what the form said on the day they signed it, and a short version log, listing each revision's start date, approver and changes, answers it quickly.

Electronic signatures for peel consent

Electronic consent works well for peels if the platform captures the right things: the signer's identity, the time, the device or login used, and the precise version on screen. Editing the template later must not alter what an earlier patient signed, the risks must appear before the signature field becomes active, and the practitioner should sign electronically too.

Online booking creates a specific trap for peels: a patient signs the light-peel form when booking and is offered a stronger peel at the visit. Make the correct form a condition of the peel actually performed. Signing ahead of time is fine, but the conversation still happens in the room and is charted before the peel. Ask counsel to confirm that your platform satisfies your state's requirements for electronic signatures and records.

When does a peel patient need to sign a new consent?

Peels are frequently sold as a series, so practices need a written rule for when a new consent is taken. The sound default is to refresh consent whenever something material changes. In practice that usually means:

• A change of agent or a move to a stronger depth category, because the risk disclosure changes with it.
• An added area the existing signature does not extend to.
• A change in the patient's health or skincare picked up when screening is repeated: a prescription started since the last visit, a pregnancy, a fresh tan or a new skin problem.
• A reaction or complication at an earlier peel, which calls for a new conversation before the next.
• A new form version, so returning patients sign the current wording.
• A different treating practitioner, where the patient agreed to treatment by a named person.

One approach is a single consent covering the course, with a short check at each visit that screening is current and nothing significant has shifted; another is a complete consent before each peel. Both can be defended. Having no written rule, or a rule that staff apply inconsistently, is much harder to defend.

What Should a Chemical Peel Consent Form Template Look Like?

A usable peel template follows the order in which the patient experiences the treatment and lets an auditor find each element quickly. The table below is a skeleton of section headings, not wording; the text of each section comes from your medical director and is reviewed by counsel.

Resist pasting a supplier's patient leaflet in as the consent. Use the product's labeling and technical information as a source for what must be disclosed, and then draft the wording yourself in language a patient can follow.

For the wider set of forms a practice keeps, and where the peel form fits among them, see our med spa consent forms guide.

Which Chemical Peel Consent Mistakes Cause the Most Trouble?

Peel complaints that escalate to a board, an insurer or a lawyer's letter tend to expose the same handful of weaknesses. Most are not missing documents; they are documents that do not match what was done.

A single "skin services" consent for everything

A combined form that covers facials, peels, dermaplaning and lasers in a paragraph each cannot do justice to any of them. The peel paragraph typically omits depth, says nothing about darker skin, and lists no screening questions. Peels deserve their own form, and each depth category your practice performs deserves its own disclosure.

The peel changed but the form did not

Practices change suppliers, add a stronger peel for a nurse to perform, or introduce a combination peel, and the consent stays as it was. Patients then sign a document describing a treatment they are not receiving. Make a consent review part of introducing any new peel product, and do it before the first patient is treated.

Pigment risk buried or softened

"Possible temporary discoloration" is not a disclosure of a risk that may be lasting and that falls more heavily on some patients than others. Name darkening and lightening separately, say who is at higher risk, and make sure the conversation and the chart show the practitioner raised it with those patients.

Screening collected but not reviewed

A patient who ticked "yes" to recent isotretinoin or a fresh tan and was peeled anyway, with no note explaining why, is in a stronger position than one who was never asked. Screening only protects the practice if someone with authority reads it before the peel and records what they decided. Our complications guide makes the same point about contraindication screens that are collected and then ignored.

No warning signs or nobody to call

Infections and cold-sore outbreaks on peeled skin are much easier to manage when caught early. A patient who waited because they thought spreading crusts were normal peeling, or who could not reach anyone over a weekend, will point to a form that never told them what to look for. Our infection control protocol guide covers the practice controls that sit behind those warning signs.

How Does the Consent Form Fit With Your Peel Protocol and Aftercare Handout?

The consent form, the peel protocol and the aftercare handout describe one treatment from three angles, and they must agree. If the protocol screens for retinoid use, the form asks about it. If the protocol defines the depth categories your practice performs, the form uses the same labels. If the handout lists symptoms that mean call the practice, the form lists the same ones. If the form promises an out-of-hours number, someone answers it. A reviewer who finds the three documents contradicting one another will read the contradiction against the practice.

It also helps to keep the peel form structurally consistent with your other procedure forms. The attestation, photography, signature and version-control sections can be shared across every procedure form, which makes training and audit simpler, while the treatment, risk and screening sections stay specific to peels. Our neurotoxin consent guide, dermal filler consent form guide and microneedling consent form guide apply the same shared structure to other treatments, and our laser hair removal consent form guide extends it to energy devices.

Finally, schedule a review. Peel products, staffing and state rules all change, and a form that was accurate when approved can drift out of date without anyone touching it. Tie a consent review to any change of peel product, practitioner role or protocol, and to a fixed annual date in between, and record the medical director's sign-off each time.

Key Takeaways

• The form records a discussion held by someone able to answer clinical questions about the specific peel; it does not replace that discussion.
• Who may perform each peel depth depends on your state and the practitioner's licence; confirm it before assigning peels.
• Name the agent and the depth category, and keep strengths and recovery periods in the protocol and handout unless your medical director chooses to print them from the approved formulary.
• List each risk separately, and say plainly that pigment change is more likely in darker skin types and after sun exposure.
• Put screening questions on the form and clinical rules in the protocol, with the practitioner's review recorded.
• Use a distinct disclosure for each depth category; deep peels sit with a physician and their own consent documentation.
• Record the patient's sun-protection and aftercare commitments, print the warning signs, and give a contact that is answered.
• Refresh consent when the agent, depth, area, practitioner or patient's health changes, and archive every version of the form.
• Start from a free PDF if you like, but the finished wording carries your medical director's sign-off and a healthcare lawyer's review.

This page gives general information on organizing and maintaining chemical peel consent documents. It is not medical or legal advice, sets no clinical standard and does not state the law of any state. No patient should sign until the medical director has approved the wording and healthcare counsel has reviewed it.